Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 2.585
+0.025 (0.98%)
Aug 27, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 654.41 | 492.93 | 255.89 | 76.61 | 17.6 | - |
| 654.41 | 492.93 | 255.89 | 76.61 | 17.6 | - | |
Revenue Growth | 76.55% | 92.63% | 234.02% | 335.31% | 103.13% | - |
Cost of Revenue | 257.56 | 212.58 | 131.17 | 39.24 | 9.91 | - |
Gross Profit | 396.85 | 280.36 | 124.72 | 37.37 | 7.69 | - |
Selling, General & Admin | 356.81 | 279.92 | 269.94 | 203.9 | 145.28 | 134.84 |
Research & Development | 146.32 | 145.32 | 215.09 | 171.54 | 129.53 | 186.84 |
Operating Expenses | 503.13 | 425.24 | 485.03 | 375.44 | 274.81 | 321.67 |
Operating Income | -106.28 | -144.88 | -360.31 | -338.07 | -267.12 | -321.67 |
Interest Expense | -8.55 | -8.15 | -8.61 | -7.91 | -3.67 | -3.95 |
Interest & Investment Income | 11.49 | 11.49 | 13.44 | 16.51 | 4.24 | 5.04 |
Currency Exchange Gain (Loss) | -4.53 | -4.53 | 2.02 | 4.14 | 26.03 | -10.37 |
Other Non Operating Income (Expenses) | -1,243 | 8.93 | 103.32 | 114.09 | 37.27 | 4.88 |
EBT Excluding Unusual Items | -1,351 | -137.15 | -250.14 | -211.23 | -203.25 | -326.08 |
Merger & Restructuring Charges | - | - | - | - | -0.26 | - |
Other Unusual Items | 1,243 | 1,243 | - | - | - | 0.35 |
Pretax Income | -107.79 | 1,106 | -250.14 | -211.23 | -203.51 | -325.73 |
Earnings From Continuing Operations | -107.79 | 1,106 | -250.14 | -211.23 | -203.51 | -325.73 |
Net Income | -107.79 | 1,106 | -250.14 | -211.23 | -203.51 | -325.73 |
Net Income to Common | -107.79 | 1,106 | -250.14 | -211.23 | -203.51 | -325.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 998 | 988 | 981 | 977 | 967 | 957 |
Shares Outstanding (Diluted) | 998 | 1,004 | 981 | 977 | 967 | 957 |
Shares Change | 1.10% | 2.33% | 0.44% | 1.07% | 0.97% | 0.73% |
EPS (Basic) | -0.11 | 1.12 | -0.25 | -0.22 | -0.21 | -0.34 |
EPS (Diluted) | -0.11 | 1.10 | -0.25 | -0.22 | -0.21 | -0.34 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.08 | -59.7 | -420.8 | 879.63 | -234.67 | -293.18 |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.43 | 0.90 | -0.24 | -0.31 |
Gross Margin | 60.64% | 56.88% | 48.74% | 48.79% | 43.69% | - |
Operating Margin | -16.24% | -29.39% | -140.80% | -441.28% | -1517.80% | - |
Profit Margin | -16.47% | 224.44% | -97.75% | -275.73% | -1156.36% | - |
Free Cash Flow Margin | -5.82% | -12.11% | -164.44% | 1148.19% | -1333.44% | - |
EBITDA | -93.93 | -131.8 | -345.99 | -322.24 | -254.82 | -309.69 |
EBITDA Margin | -14.35% | -26.74% | -135.21% | - | - | - |
D&A For EBITDA | 12.36 | 13.09 | 14.32 | 15.83 | 12.3 | 11.98 |
EBIT | -106.28 | -144.88 | -360.31 | -338.07 | -267.12 | -321.67 |
EBIT Margin | -16.24% | -29.39% | -140.80% | - | - | - |